These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29443173)

  • 21. Rapid access point of care clinic for transient ischemic attacks and minor strokes.
    O'Brien E; Priglinger ML; Bertmar C; Day S; Borsodi C; Herkes G; Krause M
    J Clin Neurosci; 2016 Jan; 23():106-110. PubMed ID: 26432497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of Australian stroke services: a prospective, multicenter study comparing dedicated stroke units with other care modalities.
    Moodie M; Cadilhac D; Pearce D; Mihalopoulos C; Carter R; Davis S; Donnan G;
    Stroke; 2006 Nov; 37(11):2790-5. PubMed ID: 17008615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of the MobileMums intervention to increase physical activity among mothers with young children: a Markov model informed by a randomised controlled trial.
    Burn E; Marshall AL; Miller YD; Barnett AG; Fjeldsoe BS; Graves N
    BMJ Open; 2015 Apr; 5(4):e007226. PubMed ID: 25926145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
    Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
    Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.
    Zhang Z; Foster JK; Kolm P; Jurkovitz CT; Parker KM; Murrah NV; Anderson GT; Douglas JS; Weintraub WS
    Am Heart J; 2006 Oct; 152(4):770-6. PubMed ID: 16996857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT).
    Tay-Teo K; Moodie M; Bernhardt J; Thrift AG; Collier J; Donnan G; Dewey H
    Cerebrovasc Dis; 2008; 26(5):475-81. PubMed ID: 18810233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute costs and predictors of higher treatment costs for major paediatric trauma in New South Wales, Australia.
    Mitchell RJ; Curtis K; Holland AJ; Balogh ZJ; Evans J; Wilson KL
    J Paediatr Child Health; 2013 Jul; 49(7):557-63. PubMed ID: 23758194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based care for alcohol use disorders is affordable.
    Corry J; Sanderson K; Issakidis C; Andrews G; Lapsley H
    J Stud Alcohol; 2004 Jul; 65(4):521-9. PubMed ID: 15376827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015.
    Valentine JC; Morrissey CO; Tacey MA; Liew D; Patil S; Ananda-Rajah M
    Mycoses; 2020 Feb; 63(2):162-171. PubMed ID: 31715052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation.
    Wilson RD; Murray PK
    Arch Phys Med Rehabil; 2005 Oct; 86(10):1941-8. PubMed ID: 16213235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost study of transient ischemic attack patients in a transient ischemic attack clinic].
    Teles de Araújo M; Canhão P
    Acta Med Port; 2011; 24(5):681-6. PubMed ID: 22525617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.
    Moodie M; Lal A; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Robertson CF; Tiddens HA; Wainwright CE;
    J Pediatr; 2014 Sep; 165(3):564-569.e5. PubMed ID: 24996984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): an Australian economic model for stroke.
    Mihalopoulos C; Cadilhac DA; Moodie ML; Dewey HM; Thrift AG; Donnan GA; Carter RC
    Int J Technol Assess Health Care; 2005; 21(4):499-505. PubMed ID: 16262974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands.
    Goossens LM; Utens CM; Smeenk FW; van Schayck OC; van Vliet M; van Litsenburg W; Braken MW; Rutten-van Mölken MP
    Value Health; 2013 Jun; 16(4):517-28. PubMed ID: 23796285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.